Alzheimers News

Medicare launched a formal process that will determine whether the agency will cover Aduhelm, the newly approved Alzheimer's drug whose high price tag and unproven benefits have prompted widespread controversy.

Following the FDA’s controversial approval of aducanumab for Alzheimer's, the head of the agency is now calling for a federal investigation into its own approval proceedings.

As advocates and critics debate the FDA's approval of the new drug, and a chorus of experts and patient advocates protest the price, many patients and their families are excited about it, hopeful that it will stop the debilitating disease from getting worse .

A consumer advocacy group is calling for the removal of three top FDA officials, saying the agency's approval of the Alzheimer's drug aducanumab (Aduhelm) was "reckless."

A man has received the first infusion of a new Alzheimer’s drug that drew criticism from some doctors after its FDA approval last week.

As the first Alzheimer's drug approved since 2003, advocates applaud the decision. Critics say the approval was based on inadequate proof that the drug works and balk at the price tag of $56,000 a year.

The drug, aducanumab, has had a rocky road to FDA approval, including a vote by an advisory committee to reject it.

The study adds to growing evidence that exposure to pollutants and chemicals in the environment plays an important role in the development of Parkinson’s, a disease of the nervous system that makes people less able to control body movements.

Short sleepers in midlife have an increased risk for dementia, independent of mental health and other factors, highlighting the importance of sleep for brain health, new research shows.

The family of famed animal expert Jack Hanna says he has been diagnosed with dementia which is in an advanced state.

An experimental drug appeared to slow cognitive decline in people with early Alzheimer’s disease, according to newly published research.

Many older adults with dementia are prescribed dangerous combinations of drugs that raise their risk of overdose, falls and further mental deterioration, a new study finds.

A new report finds U.S. racial and ethnic minority communities expect and experience more barriers when accessing dementia care.

Researchers may have uncovered a key reason some people remain sharp as a tack into their 80s and 90s.

Older men whose blood pressure rises at night may be at increased risk for Alzheimer's disease, a new study suggests.

As Tony Bennett releases what may well be his last album, his family has disclosed that the 1950s crooner who became popular with younger audiences decades later has Alzheimer's disease.

Older people diagnosed with dementia or Alzheimer's were more likely to miss credit card payments as early as six years before their diagnosis, compared with similar people without dementia (about 8% versus 7%), the researchers found.

Could vaccines play a role in preventing Alzheimer’s disease? Researchers are looking at that question more broadly after finding that the flu and pneumonia vaccines might also help protect against the devastating memory loss of Alzheimer's disease.

Older adults with memory problems may progress to Alzheimer's more quickly if they are also suffering from anxiety symptoms, a preliminary study suggests.

The boy already has lost some of what he's learned in his short time on Earth, and every day he loses a little more.

Offering fresh insight into the deep-seated roots of dementia, new research finds that diminished blood flow to the brain is tied to buildup a protein long associated with Alzheimer's disease.

The nine-year study of more than 2,000 older adults -- average age 74 -- found that people with severe apathy (a lack of interest or concern) were 80% more likely to develop dementia during the study period than those with low apathy.

New research suggests that people taking the drug appear to have significantly slower declines in thinking and memory as they age.

Many people who carry the risky variants never develop the disease; and many people who have Alzheimer’s don’t carry these genes. Knowledge of your status, then, can be unnecessarily frightening or falsely comforting.

A study led by Swedish researchers found the test did more than differentiate between Alzheimer's and other types of dementia.